YOUR ROLE Our Biotechnology team is looking for an Equity Research Analyst. In this role you will be part of a small and passionately curious team, highly skeptical of any information but at the same time hopelessly optimistic that the industry will deliver on its promise to deliver outstanding care for patients and prolong human life. Together, you will be leveraging BIT Capital’s resources, including expert networks, alternative datasets and proprietary research tools and deliver best-in-class returns to our fund investors. Equity research: Search, identify and evaluate unique investment opportunities, particular focus on the assets in clinical development stage Perform excruciatingly detailed Due Diligence (you will need to know everything that company published, including in all SEC filings – especially the small print) Commercial modeling – detailed understanding of value generation in Biopharma industry, comfortable with NPV modeling Working with data engineering team to establish proprietary database of all drug in Developments Idea generation: Attending in person and virtually medical conferences Networking and interviewing key opinion leaders to capture the next generation of innovation Regularly monitor and interpret the latest trends in assigned therapeutic areas Performance Reporting: Assist Portfolio Manager and Head of Operations with daily and monthly performance attribution reporting and subsequent inclusion in marketing materials. YOUR PROFILE MD or PhD degree with a good understanding of the drug development process and regulatory environment 3-5 years of experience in investment banking, buy-side analyst/associate, BD&L departments of big pharma companies, or strategic consulting focused on the healthcare industry Excellent communication skills in English, both written and verbal, German language is a welcome add-on Programming skills are a plus, the ability to fluently communicate with data engineers is a must A driven, highly intelligent individual with a knack for problem-solving and a keen eye for detail OUR BENEFITS The opportunity to become part of a unique European success story in asset management Meaningful learning and growth opportunities within the asset management industry A collaborative and supportive work environment An experienced, international team with professional colleagues Flat hierarchy and thus direct interaction with the management of BIT Capital Competitive compensation package CONTACT INFORMATION Please submit the following: Your resume including 2 references A cover letter addressing the following aspects/questions: What attracts you to the investment industry? In biotech therapeutics sector: What is the significantly overlooked opportunity in drug development at the moment? What is the technology that is most generously valued today? Are we in the middle of an obesity-related bubble or is the field fairly valued? What is something that will happen during the next 10-15 that will surprise most people? We are looking forward to hearing from you About us BIT Capital is the asset manager for the digital age. We are a tech company founded in 2017 by digital entrepreneur and investor Jan Beckers. As an active asset manager, BIT Capital focuses on the most promising technologies and the world's leading companies in this field. Our team consists of financial experts, digital entrepreneurs, data experts, and software developers. Analysts and algorithms form a team at BIT Capital. We combine the power of people, data, and technology for optimal performance. We develop financial products based on our technology expertise and our understanding of global trends and their impact on the financial markets. We are a tech company that invests in the best tech companies in the world. This way, we want to give investors access to the exciting investment opportunities of our time and enable them to participate in the value growth of these companies.